Cart
sales@molnova.com
Cephalotaxine
CAS No. 24316-19-6
Cephalotaxine( (-)-Cephalotaxine, Cephalotaxine )
Catalog No. M17450 CAS No. 24316-19-6
Cephalotaxine is an antiviral and an antitumor agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 43 | In Stock |
|
| 5MG | 49 | In Stock |
|
| 10MG | 69 | In Stock |
|
| 25MG | 123 | In Stock |
|
| 50MG | 176 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCephalotaxine
-
NoteResearch use only, not for human use.
-
Brief DescriptionCephalotaxine is an antiviral and an antitumor agent.
-
DescriptionCephalotaxine is an antiviral and antitumor agent.
-
In VitroCephalotaxine inhibits Zika infection by impeding viral replication and stability.
-
In Vivo——
-
Synonyms(-)-Cephalotaxine, Cephalotaxine
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorAntiviral
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number24316-19-6
-
Formula Weight315.37
-
Molecular FormulaC18H21NO4
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL; 317.10 mM
-
SMILESO[C@H]1[C@@H]2[C@@]3(N(CCc4c2cc2OCOc2c4)CCC3)C=C1OC
-
Chemical Name(11bS,12S,14aR)-13-methoxy-2,3,5,6,11b,12-hexahydro-1H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepin-12-ol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. M A Sells, et al. J Virol. 1988 Aug; 62(8): 2836–2844.
molnova catalog
related products
-
CCF642
CCF642 is a novel PDI-inhibiting compound with antimyeloma activity.
-
ICA-105574
ICA-105574 is an activator of hERG that binds to the channel to remove inactivation, thus increasing peak current amplitude and shortening the action potential. It also modulates activation kinetics of the channel.
-
AG-1517
PD153035 hydrochloride is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM in cell-free assays; little effect noted against PGDFR, FGFR, CSF-1, InsR and Src.
